JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 5 800-803
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorberboym, M.
Right arrow Articles by Sacher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lorberboym, M.
Right arrow Articles by Sacher, M.

Avid Uptake of Technetium-99m-HMPAO by an Intracranial Plasmacytoma during Carotid Balloon Test Occlusion

Mordechai Lorberboym, David Segal, Josef Machac, Chandranath Sen and Michael Sacher

Division of Nuclear Medicine, Department of Radiology and Departments of Neurosurgery and Diagnostic Radiology, Mount Sinai School of Medicine, New York, New York

Correspondence: For correspondence or reprints contact: Mordechai Lorberboym, MD, Department of Nuclear Medicine, Mount Sinai Medical Center, One Gustave L. Levy Pl., New York, NY 10029.

ABSTRACT

A 56-yr-old woman was evaluated for removal of a tumor at the base of the skull. A test to determine the risk of carotid artery sacrifice was performed prior to surgery using carotid balloon occlusion of the left internal carotid artery and 99mTc-HMPAO perfusion scintigraphy during the occlusion. An unusual intense focus of increased uptake was seen at the site of the primary tumor in the left cavernous sinus. The tumor, found to be plasmacytoma at surgery, demonstrated only mild washout from 30 min to 2 hr after administration of 99mTc-HMPAO, with a tumor-to-cerebellum ratio of 1.6 and 1.5, respectively, and a tumor-to-contralateral cranial ratio of 2.5 and 2.4, respectively. Intracranial plasmacytoma shows good response to radiation therapy, and the differentiation of this tumor from other neoplasms is pertinent to the mode of treatment and surgical approach. Technetium-99m-HMPAO SPECT imaging may be a useful tool in distinguishing these tumors from other neoplasms at the base of the skull.

Key Words: technetium-99m-HMPAO • carotid artery • occlusion • intracranial plasmacytoma • single-photon emission computed tomography







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.